A detailed history of Koss Olinger Consulting, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Koss Olinger Consulting, LLC holds 800,000 shares of PACB stock, worth $1.56 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
800,000
Previous 800,000 -0.0%
Holding current value
$1.56 Million
Previous $1.1 Million 24.09%
% of portfolio
0.12%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$1.36 - $3.65 $1.09 Million - $2.92 Million
800,000 New
800,000 $1.1 Million
Q4 2023

Feb 13, 2024

BUY
$5.97 - $10.36 $597,000 - $1.04 Million
100,000 New
100,000 $981,000
Q1 2023

May 12, 2023

BUY
$7.94 - $12.02 $476,400 - $721,200
60,000 New
60,000 $694,000
Q3 2021

Nov 09, 2021

SELL
$24.86 - $35.02 $372,900 - $525,300
-15,000 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$26.38 - $51.15 $395,700 - $767,250
15,000 New
15,000 $500,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Koss Olinger Consulting, LLC Portfolio

Follow Koss Olinger Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.